Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1999
08/26/1999WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999WO1999042580A2 Gaba receptors and their uses
08/26/1999WO1999042577A2 Biotin-binding receptor molecules
08/26/1999WO1999042574A1 Sequences of an ih ionic channel and the use thereof
08/26/1999WO1999042564A2 Apoptotic cell-mediated antigen presentation to dendritic cells
08/26/1999WO1999042486A1 Method of producing mouse and human endostatin
08/26/1999WO1999042477A2 Transporter protein for saccharide-coupled medicaments
08/26/1999WO1999042138A1 The use of bjerknes forces to manipulate contrast agents
08/26/1999WO1999042137A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
08/26/1999WO1999042121A1 Modified heat shock protein-antigenic peptide complex
08/26/1999WO1999042091A2 Use of polycations as endosomolytic agents
08/26/1999WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear
08/26/1999WO1999041978A1 Performance enhancement
08/26/1999WO1999032606A3 Neural precursor cells, method for the production and use thereof in neural defect therapy
08/26/1999WO1999031136A3 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
08/26/1999WO1999029883A3 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease
08/26/1999WO1999029844A3 Novel retroelements zam and idemfix, and their integrase
08/26/1999WO1999027094A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999020774A3 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors
08/26/1999DE19807265A1 New adenoviral vector useful for gene therapy
08/26/1999CA2321958A1 Method of producing mouse and human endostatin
08/26/1999CA2321186A1 Apoptosis inducing molecule ii and methods of use
08/26/1999CA2321101A1 Modified heat shock protein-antigenic peptide complex
08/26/1999CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
08/26/1999CA2319039A1 Biotin-binding receptor molecules
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/25/1999EP0937145A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
08/25/1999EP0937143A2 Secreted proteins and polynucleotides encoding them
08/25/1999EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells
08/25/1999EP0937102A1 Human monocyte chemotactic proprotein
08/25/1999EP0937099A1 Oligomers which inhibit the expression of interleukin genes
08/25/1999EP0937098A1 Recombinational cloning using engineered recombination sites
08/25/1999EP0936902A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
08/25/1999EP0783482A4 Cationic transport reagents
08/25/1999CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
08/25/1999CN1226835A -i gene transfer methods for wound healing
08/25/1999CN1226830A Egg anti-inflammatory composition, method of isolation and use
08/24/1999US5942496 Methods and compositions for multiple gene transfer into bone cells
08/24/1999US5942434 Regulatory sequence from phophoglycerate kinase operably linked to coding sequence of exogenous gene; for gene therapy; in situ expression of enzymes which convert prodrugs to active anticarcinogenic/antitumor drugs or cytokines
08/24/1999US5942433 Dna coding for a nucleic acid binding protein with n-terminal modified by addition of acidic amino acids forming domain for stable dimerization or multimerization with cell proteins; for controlling transcription factors by gene therapy
08/24/1999US5942419 RsbW-1 encoding nucleic acids
08/24/1999US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides
08/24/1999US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation
08/24/1999US5942401 An in vitro assay detecting the presence of cytotoxic t-cell response to rev and or tat proteins
08/24/1999US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy
08/24/1999CA2248972A1 Novel compounds
08/24/1999CA2082044C Modulation of gene expression through interference with rna secondary structure
08/20/1999CA2261183A1 Adenoviral transfer vector for the gene transport of a dna sequence
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041416A2 Compositions comprising viruses and methods for concentrating virus preparations
08/19/1999WO1999041412A1 A novel npg-1 gene that is differentially expressed in prostate tumors
08/19/1999WO1999041407A1 Method for developing a pharmaceutical active ingredient
08/19/1999WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999WO1999041399A1 Methods for purified aav vector production
08/19/1999WO1999041398A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
08/19/1999WO1999041397A1 Anti-viral vectors
08/19/1999WO1999041396A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999WO1999041385A1 Mekk1 proteins and fragments thereof for use in regulating apoptosis
08/19/1999WO1999041381A1 Neuroserpin
08/19/1999WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999WO1999041372A1 Potassium channel polypeptide
08/19/1999WO1999041369A2 Genetic vaccine vector engineering
08/19/1999WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999WO1999041366A1 Introduction of nucleic acid into skin cells by topical application
08/19/1999WO1999041364A2 Compositions and methods for wound healing
08/19/1999WO1999041359A1 Modified adenovirus containing a fiber replacement protein
08/19/1999WO1999041355A2 Hiv chemokines
08/19/1999WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999WO1999041271A1 High affinity nucleic acid ligands of complement system proteins
08/19/1999WO1999041258A1 Novel dimerizing agents, their production and use
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040945A2 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
08/19/1999WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999WO1999040783A1 Method of controlling proliferation and differentiation of stem and progenitor cells
08/19/1999WO1999040771A2 Concurrent flow mixing for preparing compositions comprising gene therapy vectors
08/19/1999WO1999030741A3 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
08/19/1999WO1999029871A3 Circovirus sequences related to piglet weight loss disease (pwd)
08/19/1999WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof
08/19/1999WO1999023215A9 Materials and methods for preventing cellular injury in humans and animals
08/19/1999WO1999023108A9 Inducible phosphofructokinase and the warburg effect
08/19/1999WO1999014355A3 Highly affine nucleic acid molecules, production and application of same
08/19/1999WO1999012945A3 Hydrophobic glycosylamine derivatives, compositions, and methods for use
08/19/1999DE19859526A1 Pharmaceutical composition, especially for gene transfer and therapy
08/19/1999CA2723040A1 Compositions comprising viruses and methods for concentrating virus preparations
08/19/1999CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999CA2321135A1 Modified adenovirus containing a fiber replacement protein
08/19/1999CA2321097A1 Anti-viral vectors
08/19/1999CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320515A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999CA2320513A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
1 ... 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 ... 870